{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:18:00Z","timestamp":1774016280059,"version":"3.50.1"},"reference-count":86,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Gastric cancer (GC) patients with peritoneal metastasis tend to achieve poor clinical outcomes. Until recently, the treatment options were limited mainly to either palliative chemotherapy or radiation therapy in exceptional cases. Currently, these patients benefit from multimodal treatment, such as cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Despite good overall results, this treatment modality is still widely debated. The following study is designed to assess the papers about the possible application and utility of HIPEC in GC. A search in the PubMed, Web of Science, and Scopus databases was performed to assess the papers devoted to the role of HIPEC in GC treatment; a literature search was performed until March 21st; and, finally, 50 studies with a total number of 3946 patients were analyzed. According to the most recent data, it seems to be reasonable to limit the duration of HIPEC to the shortest effective time. Moreover, the drugs used in HIPEC need to have equal concentrations and the same solvent. Perioperative chemotherapy needs to be reported in detail and, furthermore, the term \u201cmorbidity\u201d should be defined more clearly by the authors.<\/jats:p>","DOI":"10.3390\/ijerph19020681","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T20:29:26Z","timestamp":1641760166000},"page":"681","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hyperthermic Intraperitoneal Chemotherapy in the Management of Gastric Cancer: A Narrative Review"],"prefix":"10.3390","volume":"19","author":[{"given":"Marek","family":"Mazurek","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Voivodship Hospital in Siedlce, 08-110 Siedlce, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Szlendak","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland"},{"name":"Department of Oncology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-7627","authenticated-orcid":false,"given":"Alicja","family":"Forma","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-8987","authenticated-orcid":false,"given":"Jacek","family":"Baj","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-9649","authenticated-orcid":false,"given":"Ryszard","family":"Maciejewski","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giandomenico","family":"Roviello","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Florence, 50139 Florence, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9777-9588","authenticated-orcid":false,"given":"Luigi","family":"Marano","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Surgical Oncology, University of Siena, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Roviello","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Surgical Oncology, University of Siena, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karol","family":"Polom","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Medical University of Gdansk, 80-070 Gdansk, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7267-9516","authenticated-orcid":false,"given":"Robert","family":"Sitarz","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Medical University of Lublin, 20-090 Lublin, Poland"},{"name":"Department of Surgical Oncology, St. John\u2019s Cancer Center, 20-090 Lublin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,7]]},"reference":[{"key":"ref_1","first-page":"83","article-title":"Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer","volume":"16","author":"Sugarbaker","year":"1989","journal-title":"Semin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.ejso.2016.03.016","article-title":"A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent","volume":"42","author":"Yonemura","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_3","first-page":"143","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy: An evidence-based review-past, present and future","volume":"7","author":"Dehal","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Dewhirst, M.W., and Kirsch, D. (2018). Technological Advances, Biologic Rationales, and the Associated Success of Chemotherapy with Hy-perthermia in Improved Outcomes in Patients with Sarcoma. JAMA Oncol., 4.","DOI":"10.1001\/jamaoncol.2017.4941"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/02656736.2015.1091093","article-title":"The future of biology in driving the field of hyperthermia","volume":"32","author":"Dewhirst","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1016\/S0360-3016(03)01088-5","article-title":"Hyperthermia improves the complete response rate for superficial tumors treated with radiation: Results of a prospective randomized trial testing the thermal dose parameter CEM 43\u00b0 T90","volume":"57","author":"Jones","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2017.03.030","article-title":"The 30-year experience-A meta-analysis of random-ised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer","volume":"79","author":"Desiderio","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1200\/JCO.2004.08.026","article-title":"Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial","volume":"22","author":"Hartgrink","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jss.2019.03.036","article-title":"Perioperative Morbidity of Gastrectomy during CRS-HIPEC: An ACS-NSQIP Analysis","volume":"241","author":"Paredes","year":"2019","journal-title":"J. Surg. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.ejso.2021.05.016","article-title":"Prognostic impact of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in gastric cancer patients: A meta-analysis of randomized controlled trials","volume":"47","author":"Granieri","year":"2021","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.suronc.2019.01.005","article-title":"HIPEC and CRS in peritoneal metastatic gastric cancer\u2014Who really benefits?","volume":"28","author":"Hotopp","year":"2019","journal-title":"Surg. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.4251\/wjgo.v10.i10.282","article-title":"Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis","volume":"10","author":"Leiting","year":"2018","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/02656736.2017.1291999","article-title":"Drugs, doses, and durations of intraperitoneal chemotherapy: Standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma","volume":"33","author":"Lemoine","year":"2017","journal-title":"Int. J. Hyperth."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3748\/wjg.v22.i3.1114","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer","volume":"22","author":"Seshadri","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s13193-016-0502-8","article-title":"The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer","volume":"7","author":"Seshadri","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ags3.12060","article-title":"Treatment of patients with peritoneal metastases from gastric cancer","volume":"2","author":"Kitayama","year":"2018","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/pp-2017-0011","article-title":"Pharmacology of chemotherapy treatments for peritoneal metastases: Optimizing and augmenting HIPEC","volume":"2","author":"Sugarbaker","year":"2017","journal-title":"Pleura Peritoneum."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5230\/jgc.2018.18.e32","article-title":"Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer","volume":"18","author":"Kim","year":"2018","journal-title":"J. Gastric Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.21037\/jgo.2017.03.11","article-title":"Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis","volume":"8","author":"Fugazzola","year":"2017","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/cam4.877","article-title":"Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomato-sis: A propensity score-matched analysis","volume":"5","author":"Geng","year":"2016","journal-title":"Cancer Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/02656736.2016.1190987","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study","volume":"32","author":"Tu","year":"2016","journal-title":"Int. J. Hyperth."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1245\/s10434-013-3327-5","article-title":"Aggressive locoregional surgical therapy for gastric peri-toneal carcinomatosis","volume":"21","author":"Magge","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemo-hyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch. Surg."},{"key":"ref_24","first-page":"20","article-title":"Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan","volume":"139","author":"Mizumoto","year":"2012","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemother-apy improves survival of patients with peritoneal carcinomatosis from gastric cancer: Final results of a phase III randomized clinical trial","volume":"18","author":"Yang","year":"2011","journal-title":"Ann. Surg. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21519","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and\/or peritoneal carcinomatosis: Results from a Chinese center","volume":"101","author":"Yang","year":"2010","journal-title":"J. Surg. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/bjs.4695","article-title":"Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion","volume":"92","author":"Yonemura","year":"2005","journal-title":"Br. J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.gassur.2003.12.014","article-title":"Cytoreductive surgery with intraperitoneal hyperther-mic chemotherapy for advanced gastric cancer","volume":"8","author":"Hall","year":"2004","journal-title":"J. Gastrointest. Surg."},{"key":"ref_29","first-page":"1776","article-title":"Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: Final results of a randomized controlled study","volume":"48","author":"Yonemura","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<529::AID-CNCR3>3.0.CO;2-9","article-title":"Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma","volume":"85","author":"Fujimoto","year":"1999","journal-title":"Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C","article-title":"Improved mortality rate of gastric carcinoma pa-tients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery","volume":"79","author":"Fujimoto","year":"1997","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0039-6060(96)80145-0","article-title":"Effects of intraoperative chemohyperthermia in pa-tients with gastric cancer with peritoneal dissemination","volume":"119","author":"Yonemura","year":"1996","journal-title":"Surgery"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/BF01675656","article-title":"Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination","volume":"15","author":"Yonemura","year":"1991","journal-title":"World J. Surg."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ejso.2007.12.003","article-title":"Advanced gastric cancer with or without peritoneal carcinomatosis treated with hyperthermic intraperitoneal chemotherapy: A single western center experience","volume":"34","author":"Scaringi","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.ejso.2020.11.139","article-title":"Peritoneal cancer index (PCI) based patient selecting strategy for complete cytore-ductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single center ret-rospective analysis of 125 patients","volume":"47","author":"Ji","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1245\/s10434-020-08968-8","article-title":"Laparoscopic HIPEC for Low-Volume Peritoneal Metas-tasis in Gastric and Gastroesophageal Adenocarcinoma","volume":"27","author":"Blumenthaler","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/00015458.2006.11679896","article-title":"Adjuvant hyperthermic intraperitoneal peroperative chem-otherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience","volume":"106","author":"Detroz","year":"2006","journal-title":"Acta Chir. Belg."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Topal, B., Demey, K., Topal, H., Jaekers, J., Van Cutsem, E., Vandecaveye, V., Sagaert, X., and Prenen, H. (2017). Cytoreductive surgery and Hyperthermic intra-operative peritoneal chemotherapy with Cisplatin for gastric peritoneal Carcinomatosis Monocentric phase-2 nonrandomized prospective clinical trial. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3730-6"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.18.01688","article-title":"Cytoreductive Surgery with or without Hyperther-mic Intraperitoneal Chemotherapy for Gastric Cancer with Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analy-sis","volume":"37","author":"Bonnot","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1002\/cam4.2204","article-title":"Hyperthermic intraperitoneal chemo-therapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central-Eastern European study","volume":"8","author":"Yarema","year":"2019","journal-title":"Cancer Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10120-019-00978-0","article-title":"Peritoneal metastasis in gastric cancer: Results from the German data-base","volume":"23","author":"Rau","year":"2020","journal-title":"Gastric Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.ejso.2018.06.036","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis","volume":"44","author":"Manzanedo","year":"2018","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1245\/s10434-016-5306-0","article-title":"CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer","volume":"23","author":"Boerner","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ejso.2016.04.053","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center","volume":"42","author":"Wu","year":"2016","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jso.23633","article-title":"Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial","volume":"110","author":"Rudloff","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5230\/jgc.2014.14.2.117","article-title":"Initial clinical experience with cytoreductive surgery and hyper-thermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases","volume":"14","author":"Konigsrainer","year":"2014","journal-title":"J. Gastric Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/02656736.2014.893451","article-title":"Hyperthermic intraperitoneal chemoperfu-sion in combined treatment of locally advanced and disseminated gastric cancer: Results of a single-centre retrospective study","volume":"30","author":"Yarema","year":"2014","journal-title":"Int. J. Hyperth."},{"key":"ref_48","first-page":"2019","article-title":"The role of prophylactic hyperthermic intraperitoneal chemotherapy in the management of serosal involved gastric cancer","volume":"34","author":"Saladino","year":"2014","journal-title":"Anticancer Res."},{"key":"ref_49","first-page":"703","article-title":"Systemic Chemotherapy using FLOT\u2014Regimen Combined with Cytoreductive Surgery plus HIPEC for Treatment of Peritoneal Metastasized Gastric Cancer","volume":"61","author":"Muller","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_50","first-page":"1","article-title":"Intraperitoneal chemotherapy and its evolving role in management of gastric cancer with peritoneal metastases","volume":"26","author":"Canbay","year":"2014","journal-title":"Chin. J. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3109\/0284186X.2012.702925","article-title":"Phase II study of patients with peritoneal carcinomato-sis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemo-therapy","volume":"52","author":"Hultman","year":"2013","journal-title":"Acta Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Costa, W.L., Coimbra, F.J.F., Ribeiro, H.S., Diniz, A.L., de Godoy, A.L., Begnami, M., Silva, M.J.B., Fanelli, M.F., and Mello, C.A.L. (2012). Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients. World J. Surg. Oncol., 10.","DOI":"10.1186\/1477-7819-10-195"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhu, L., Xu, Z., Wu, Y., Liu, P., Qian, J., Yu, S., Xia, B., Lai, J., Ma, S., and Wu, Z. (2020). Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces perito-neal metastasis in gastrin cancer: A retrospective clinical study. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07339-6"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/jso.26366","article-title":"Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial","volume":"123","author":"Koemans","year":"2021","journal-title":"J. Surg. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1245\/s10434-020-09465-8","article-title":"Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned","volume":"28","author":"Koemans","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.21037\/jgo-21-20","article-title":"Laparoscopic distal gastrectomy and hyperthermic intraperitoneal chemother-apy in the treatment of advanced gastric cancer: A retrospective case-matched study on perioperative outcomes","volume":"12","author":"Yin","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rosa, F., Galiandro, F., Ricci, R., Di Miceli, D., Longo, F., Quero, G., Tortorelli, A.P., and Alfieri, S. (2021). Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: Experience from a Western tertiary referral center. Langenbeck\u2019s Arch. Surg.","DOI":"10.1007\/s00423-021-02137-5"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Yu, P., Ye, Z., Dai, G., Zhang, Y., Huang, L., Du, Y., and Cheng, X. (2020). Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastrin cancer patients with limited peritoneal metastasis: A prospective cohort study. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07601-x"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"794","DOI":"10.21147\/j.issn.1000-9604.2020.06.12","article-title":"Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal me-tastasis: A multicenter propensity scorematched cohort study","volume":"32","author":"Lei","year":"2020","journal-title":"Chin. J. Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: A multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1245\/s10434-015-5081-3","article-title":"Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?","volume":"23","author":"Chia","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1245\/s10434-019-07450-4","article-title":"Cytoreductive Surgery and Hyper-thermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)","volume":"26","author":"Manzanedo","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1245\/s10434-020-08842-7","article-title":"Factors Associated with Resection and Survival After Laparo-scopic HIPEC for Peritoneal Gastric Cancer Metastasis","volume":"27","author":"White","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1097-0142(19940415)73:8<2048::AID-CNCR2820730806>3.0.CO;2-Q","article-title":"Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study","volume":"73","author":"Hamazoe","year":"1994","journal-title":"Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","article-title":"Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: Randomized controlled study","volume":"18","author":"Fujimura","year":"1994","journal-title":"World J. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4251\/wjgo.v12.i7.782","article-title":"Role of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer","volume":"12","author":"Xie","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Fan, B., Bu, Z., Zhang, J., Zong, X., Ji, X., Fu, T., Jia, Z., Zhang, Y., and Wu, X. (2021). Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-07925-2"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/jog.14391","article-title":"Yoshida Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer","volume":"46","author":"HTsuyoshi","year":"2020","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ejso.2020.02.010","article-title":"Past, present and future of adjuvant HIPEC in patients at high risk for colorectal peritoneal metastases","volume":"46","author":"Baratti","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Wang, X., and Li, T. (2020). Postoperative pain pathophysiology and treatment strategies after CRS + HIPEC for peritoneal cancer. World J. Surg. Oncol., 18.","DOI":"10.1186\/s12957-020-01842-7"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13193-016-0504-6","article-title":"Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Me-tastases","volume":"7","author":"Mehta","year":"2016","journal-title":"Indian J. Surg. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.soc.2018.02.009","article-title":"Learning Curve, Training Program, and Monitorization of Surgical Performance of Peritoneal Surface Malignancies Centers","volume":"27","author":"Kusamura","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2013.12.028","article-title":"Minimally invasive secondary cytoreduction plus HIPEC for recurrent ovarian cancer: A case series","volume":"132","author":"Fagotti","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Petrillo, M., Zucchetti, M., Cianci, S., Morosi, L., Ronsini, C., Colombo, A., D\u2019Incalci, M., Scambia, G., and Fagotti, A. (2019). Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study. J. Gynecol. Oncol., 30.","DOI":"10.3802\/jgo.2019.30.e59"},{"key":"ref_75","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: A review of hyperthermic intraperito-neal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4251\/wjgo.v2.i2.85","article-title":"Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer","volume":"2","author":"Yonemura","year":"2010","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Montori, G., Coccolini, F., Ceresoli, M., Catena, F., Colaianni, N., Poletti, E., and Ansaloni, L. (2014). The treatment of peritoneal carcinomatosis in advanced gastric cancer: State of the art. Int. J. Surg. Oncol., 2014.","DOI":"10.1155\/2014\/912418"},{"key":"ref_78","unstructured":"National Institutes of Health (2009). Common Terminology Criteria for Adverse Events v4.0."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: Five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Foster, J.M., Sleightholm, R., Patel, A., Shostrom, V., Hall, B., Neilsen, B., Bartlett, D., and Smith, L. (2019). Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures. JAMA Netw. Open, 2.","DOI":"10.1001\/jamanetworkopen.2018.6847"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","article-title":"A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology","volume":"28","author":"Badgwell","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s10120-019-00969-1","article-title":"The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis","volume":"22","author":"Rau","year":"2019","journal-title":"Gastric Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Graziosi, L., Marino, E., De Angelis, V., Rebonato, A., and Donini, A. (2016). Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: Analysis from a single oncological center. World J. Surg. Oncol., 14.","DOI":"10.1186\/s12957-016-0856-y"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","article-title":"Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials","volume":"40","author":"Coccolini","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_85","unstructured":"Associazione Italiana di Oncologia Medica (2021, June 14). Linee Guida Tumori Peritoneali Primitivi E Secondari. Available online: https:\/\/www.aiom.it\/wp-content\/uploads\/2019\/10\/2019_LG_AIOM_Peritoneo.pdf."},{"key":"ref_86","unstructured":"PSOGI (2021, June 14). International Recommendations for the Management of Peritoneal Metastases. Available online: http:\/\/www.psogi.com\/psogi\/international-recommendations-for-the-management-of-peritoneal-metastases\/."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/2\/681\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:13:07Z","timestamp":1760364787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/2\/681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,7]]},"references-count":86,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijerph19020681"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19020681","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,7]]}}}